US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 9, 2018 (8 years ago)

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective Container: Customer complaints of punctures in the bottle.

What was recalled

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Recalling firm
Orexigen Therapeutics, Inc.
NDC code
51267-890-99
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1099-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Bupropion recalls

See all